The Lancet
-
healthEngland HPV Vaccine Program Achieves 100% Mortality Reduction in Young Women
Landmark Lancet study confirms England's HPV vaccination scheme eliminated cervical cancer deaths in women aged 20-24, preventing approximately 200 fatalities and validating WHO elimination goals.
-
healthPCOS Renamed PMOS: A Shift from Fertility Focus to Metabolic Health
Polycystic ovary syndrome is officially renamed polyendocrine metabolic ovarian syndrome (PMOS), reframing the condition as a systemic hormonal and metabolic disorder rather than a fertility issue.
-
health1.2 Billion Now Living With Mental Health Conditions Worldwide
A new Lancet study reveals a 95% surge in mental health cases since 1990, driven by anxiety and depression.
-
healthPCOS Renamed to PMOS to End Decades of Misunderstanding
Polycystic ovary syndrome is now polyendocrine metabolic ovarian syndrome, reflecting its true nature and impacts.
-
healthWomen's Hormonal Condition PCOS Renamed to PMOS in Global Push for Accuracy
Experts rename PCOS to PMOS to reflect its metabolic and hormonal complexity, aiming to reduce misdiagnosis and stigma.
-
healthPCOS Renamed to PMOS After Global Consensus Effort
The hormonal disorder affecting 1 in 8 women is now called Polyendocrine Metabolic Ovarian Syndrome, reflecting its true nature beyond ovarian cysts.
-
healthVision Decline May Signal Dementia Risk 12 Years Early
Studies show worsening vision predicts cognitive decline decades before diagnosis, raising prevention hopes.
-
healthHormone Therapy Boosts Weight Loss Drug Results by 35% in Postmenopausal Women
Mayo Clinic study shows menopausal hormone therapy combined with tirzepatide increases weight loss by 35% in women versus drug alone.